Takeaway: Replay for Spread and Impacts of COVID-19 in the US w Dennis Grimaud (Co-Founder of DIATHERIX Laboratories) first aired on March 10 @ 3:15PM

Replay | Healthcare Speaker Call: COVID-19 Impacts

Hedgeye Subscribers: CLICK HERE for audio replay

Call Replay | HCA, THC, AMN | Spread and Impacts of COVID-19 in the US - Slide4

Details | If you weren't able to catch us live, please enjoy the replay of a very interesting conference call with Dennis Grimaud, the Co-Founder and former CEO of DIATHERIX Laboratories. DIATHERIX, which has been acquired by Eurofins, is a leader in the development of diagnostic tools to aid in the identification and treatment of viral disease including H1N1 and a host of coronavirus.

Dennis, Tom Tobin, and I discussed those topics which have been top of mind as investors try and assess the impact of COVID-19 testing, diagnosis and treatment, including:

  • What may have gone wrong in China and how that impacted mortality rates
  • Mis-steps by US in containment and the implications for the spread of disease
  • At-risk populations and complications that may give rise to hospitalizations or not.
  • Rate if Change in Testing v Rate of Change in Disease Spread
  • Regional hotspots or national impact

Please call if you have any follow- up questions.

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

Thomas Tobin
Managing Director


Twitter
LinkedIn